Rh prevention programme in Edinburgh, Scotland.
D000917:Antibody Formation / Q000187:drug effects; D000941:Antigens; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007231:Infant, Newborn; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D012606:Scotland
D000941:Antigens; D007074:Immunoglobulin G; D012204:Rh-Hr Blood-Group System